Salim Khakoo retweeted
📢 I’m recruiting PhD students for Fall 2025 at UCLA!
Please apply to @CS_UCLA or @CompMedUCLA if you are interested in ML and (Gen)AI for healthcare / medicine / science.
See my website for more on my research & how to apply: people.csail.mit.edu/yuzhe
Please retweet!
Salim Khakoo retweeted
Are you:
1. Looking for a fully-funded PhD
2. Interested in virus genome replication
3. Excited about RNA-protein interactions
4. Keen to master techniques in structural biology and single molecule, fluorescence-based imaging (TIRF, FRET)
Then get in touch! And please RT
Salim Khakoo retweeted
We have a great program for you- looking forward to seeing as many of you as can come 😀 @BASL
Great line up including @helpatologist + @UHS_LiverTeam +@adesoton
Great to see our work on defining an NK cell cancer antigen getting some media attention
independent.co.uk/news/healt…
Thanks @Peppa_Group for organising such a great day
Wonderful UK NK workshop today...thanks @Peppa_Group & team for organising...great talks, networking and meeting old & new friends. Thank you 🙏🏽 #NKcells
Salim Khakoo retweeted
JUNIOR DOCTOR - PAY EXPLAINED
2008 - 24 Tins of beans an hour
2023 - 10 Tins of beans an hour
#PayRestoration
Salim Khakoo retweeted
Thank you @britsocimm for recognising the achievements of our Antibody & Vaccine Group @CCI_UoS @Wessex_immunol @UoS_Medicine who’s contributed to many successful treatments in the fight against cancer 💪🧬🔬💉
Looking forward to attending the Awards Ceremony in London 🎉🏅
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
Salim Khakoo retweeted
Extremely grateful to @BladderCancerUS for selecting our clinical trial for their 2023 Translational Clinical Trial Award in partnership with @MattGalsky @DrJohnSfakianos to test response to monalizumab+durvalumab in BCG-unresponsive NMIBC patients targeting the HLA-E/NKG2A axis.
Congratulations to BCAN's first-ever awardees of its Translational Clinical Trial Award (TCTA)! They are @AmirHorowitz of @IcahnMountSinai and @spsutkaMD of @UWMedicine Click to read more about their exciting proposals: bcan.org/bcan-announces-awar… #bladdercancer
Salim Khakoo retweeted
"Does the donor source for an NK matter? it certainly does: specifically the KIR, HLA Class-I, KIR Ligands, Expression level" Amir Horowitz #innatekillersummit2023
Salim Khakoo retweeted
Lovely to see @NHS_HealthEdEng having a meeting #HEE10
Just in case anyone missed @gmcuk report
Data shows the colour of your skin matters-for doctors progression
In 2023
And no change over last fair few years
Talk about it. Acknowledge it. Correct it.
gmc-uk.org/-/media/documents…
Salim Khakoo retweeted
I was sacked by the BBC as a local radio presenter in 2018 just for saying I might stand against Jacob Rees-Mogg in the 2019 election. I was initially told I would just have to stand down for purdah, then someone higher up changed their mind. It’s quite a fearful organisation.
Salim Khakoo retweeted
Today we announce the appointment of Professor David Adams FMedSci, Pro-Vice Chancellor and Head of College of Medical and Dental Sciences @unibirm_MDS at the University of Birmingham @BHPComms as the next Registrar of the Academy. 🧵
acmedsci.ac.uk/more/news/aca…
Salim Khakoo retweeted
Unrealized potential of NK cells and their future use from Todd Fehniger from @WUSTL
1- NK vs T cells
2- Allo NK collection process
3- NK in the use: ongoing/incoming trials
4- You can train NK to memory NK cells to overcome short life span
#Tandem23 #CellTherapy
Salim Khakoo retweeted
Anti-LAG3+anti-PD1 was approved in 2022 in melanoma. In our latest, we looked how it invigorates immunity in 40 pts, treatment naive and pts refractory to previous immunotherapies. Besides CD8+ T cells, the main effects were seen in NKs and Tregs! 🧵 jci.org/articles/view/164809
Great paper, Malcom
Innate receptors with high specificity for HLA class I-peptide complexes biorxiv.org/cgi/content/shor… #biorxiv_immuno
Salim Khakoo retweeted
🚨OUT NOW🚨 @Nature
We show myeloid cells instruct CD8+ #Tcell function in the human #liver
Study led by the BRILLIANT @ljpally (now @pallett_lab) working with AMAZING team in @maini_lab, other @SLMS_UCL labs & external collaborators
nature.com/articles/s41586-0…
🧵⬇️🤩
Salim Khakoo retweeted
It was a great pleasure to host @RomagnaniLab in Milan and at @HumanitasMilano for a beautiful and very stimulating talk about adaptive features of innate lymphocytes!
We hope to see you soon again!
#innatelymphocytes #NKcells #adaptivefeatures



































